2015
DOI: 10.1007/s10897-014-9813-5
|View full text |Cite
|
Sign up to set email alerts
|

All in the Family: Barriers and Motivators to the Use of Cancer Family History Questionnaires and the Impact on Attendance Rates

Abstract: Data has demonstrated that family history questionnaires (FHQs) are an invaluable tool for assessing familial cancer risk and triaging patients for genetic counseling services. Despite their benefits, return rates of mailed FHQs from newly referred patients remain low, suggesting potential barriers to their use. To investigate this, a total of 461 participants, 239 who completed a FHQ (responders) and 222 who did not (non-responders), were surveyed at a subsequent appointment regarding potential barriers and m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…22 Family history collection is a well-established screening tool for evaluating hereditary cancer risk in patients, but it is time consuming and can be difficult to obtain in families with limited communication. [13][14][15][16] Although 70% of Americans report discussing family cancer history with at least one family member, fewer than one third report knowing their family cancer history well. 26 Prior findings indicate that digital tools can increase the odds of communicating with family about shared risks.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…22 Family history collection is a well-established screening tool for evaluating hereditary cancer risk in patients, but it is time consuming and can be difficult to obtain in families with limited communication. [13][14][15][16] Although 70% of Americans report discussing family cancer history with at least one family member, fewer than one third report knowing their family cancer history well. 26 Prior findings indicate that digital tools can increase the odds of communicating with family about shared risks.…”
Section: Discussionmentioning
confidence: 99%
“…11 Family history collection remains the gold standard for triaging patients into cancer-risk categories, 12 but this method is time-consuming, inaccurate, and generally underused. [13][14][15][16] Scalable and integrated solutions are needed to aid health care professionals in identifying at-risk patients.…”
Section: Methodsmentioning
confidence: 99%
“…Studies of different approaches to family history collection (eg, questionnaires, preappointment phone calls, computer‐based family history collection tools, and virtual genetic counselors) have assessed: accuracy of information collected, accuracy with which individuals at increased risk of a condition can be identified and feasibility of implementing such a tool in a clinical setting . These studies have focused on the medical utility of family history, and although some have investigated patient satisfaction and/or ease of use, none (that we were able to identify) have yet investigated the effects of different approaches to family history collection on patient outcomes of genetic counseling.…”
Section: Introductionmentioning
confidence: 99%
“…Some challenges should be considered when expanding FHH to include family medication history. It has been well-documented that FHH is under-utilized for a variety of reasons [ 42 , 43 , 44 , 45 ] and thus, suggesting collection of further information may not be feasible. In particular, evidence suggests that FHH is under-reported [ 46 , 47 , 48 , 49 , 50 ] and potentially inaccurate or incomplete [ 51 , 52 , 53 ], with patient recall, sharing, and communication impacted by multiple factors including unawareness, differences in knowledge of maternal vs. paternal family histories, patient gender, degree of relatives, and cultural factors [ 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ].…”
Section: Discussion—challenges To Clinical Implementationmentioning
confidence: 99%